Global Salbutamol Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Salbutamol Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and S-isomers. The R-isomer has 150 times greater affinity for the beta2-receptor than the S-isomer and the S-isomer has been associated with toxicity. This lead to the development of levalbuterol, the single R-isomer of salbutamol. However, the high cost of levalbuterol compared to salbutamol has deterred wide-spread use of this enantiomerically pure version of the drug. Salbutamol is generally used for acute episodes of bronchospasm caused by bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders such as chronic obstructive pulmonary disorder (COPD). It is also used prophylactically for exercise-induced asthma.
Salbutamol report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Salbutamol market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Human and Animal are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Salbutamol industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Salbutamol key manufacturers include Mylan, Armstrong Pharmaceuticals, GlaxoSmithKline, 3M Pharmaceuticals Inc, Novex, Apotex and Teva Pharmaceuticals, etc. Mylan, Armstrong Pharmaceuticals, GlaxoSmithKline are top 3 players and held % sales share in total in 2022.
Salbutamol can be divided into Solution, Aerosol, Aerosol, Spray and Inhalant, etc. Solution is the mainstream product in the market, accounting for % sales share globally in 2022.
Salbutamol is widely used in various fields, such as Human and Animal, etc. Human provides greatest supports to the Salbutamol industry development. In 2022, global % sales of Salbutamol went into Human filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Salbutamol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Mylan
Armstrong Pharmaceuticals
GlaxoSmithKline
3M Pharmaceuticals Inc
Novex
Apotex
Teva Pharmaceuticals
Segment by Type
Solution
Aerosol
Aerosol, Spray
Inhalant
Human
Animal
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Salbutamol market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Salbutamol, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Salbutamol industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Salbutamol in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Salbutamol introduction, etc. Salbutamol Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Salbutamol market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Salbutamol report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Salbutamol market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Human and Animal are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Salbutamol industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Salbutamol key manufacturers include Mylan, Armstrong Pharmaceuticals, GlaxoSmithKline, 3M Pharmaceuticals Inc, Novex, Apotex and Teva Pharmaceuticals, etc. Mylan, Armstrong Pharmaceuticals, GlaxoSmithKline are top 3 players and held % sales share in total in 2022.
Salbutamol can be divided into Solution, Aerosol, Aerosol, Spray and Inhalant, etc. Solution is the mainstream product in the market, accounting for % sales share globally in 2022.
Salbutamol is widely used in various fields, such as Human and Animal, etc. Human provides greatest supports to the Salbutamol industry development. In 2022, global % sales of Salbutamol went into Human filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Salbutamol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Mylan
Armstrong Pharmaceuticals
GlaxoSmithKline
3M Pharmaceuticals Inc
Novex
Apotex
Teva Pharmaceuticals
Segment by Type
Solution
Aerosol
Aerosol, Spray
Inhalant
Segment by Application
Human
Animal
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Salbutamol market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Salbutamol, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Salbutamol industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Salbutamol in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Salbutamol introduction, etc. Salbutamol Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Salbutamol market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices